Procept BioRobotics
Clinical trials sponsored by Procept BioRobotics, explained in plain language.
Medical device company developing robotic systems for urologic surgery.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Waterjet vs. scalpel: new trial tests gentler prostate cancer treatment Results expected Jul 2027 (estimated)
-
Waterjet vs. scalpel: new trial tests gentler prostate cancer treatment
Disease control OngoingThis study compares a new, less invasive treatment called Aquablation, which uses a high-speed waterjet to remove prostate tissue, to standard surgery (radical prostatectomy) for men with localized prostate cancer. About 280 men will be randomly assigned to one of the two treatme…
Sponsor: PROCEPT BioRobotics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Water-Jet robot takes aim at prostate cancer and urinary troubles
Disease control OngoingThis study tests a robotic system that uses a high-pressure water jet to remove prostate tissue in men with localized prostate cancer and trouble urinating. The goal is to see if the procedure is safe and works well. About 125 men will be followed for one year after treatment.
Sponsor: PROCEPT BioRobotics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC